203 related articles for article (PubMed ID: 20373880)
1. Nona-D-arginine amide for prophylaxis and treatment of experimental Pseudomonas aeruginosa keratitis.
Karicherla P; Hobden JA
Curr Eye Res; 2010 Mar; 35(3):220-4. PubMed ID: 20373880
[TBL] [Abstract][Full Text] [Related]
2. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
Karicherla P; Hobden JA
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
[TBL] [Abstract][Full Text] [Related]
3. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
[TBL] [Abstract][Full Text] [Related]
4. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
[TBL] [Abstract][Full Text] [Related]
5. Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit.
Levy JH; Katz HR
Ann Ophthalmol; 1990 May; 22(5):179-83. PubMed ID: 2114813
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
Jensen H; Zerouala C; Carrier M; Short B
J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
[TBL] [Abstract][Full Text] [Related]
7. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
[TBL] [Abstract][Full Text] [Related]
8. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
[TBL] [Abstract][Full Text] [Related]
9. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
[TBL] [Abstract][Full Text] [Related]
10. Perineural infiltrates in Pseudomonas keratitis.
Robbie SJ; Vega FA; Tint NL; Hau S; Allan B
J Cataract Refract Surg; 2013 Nov; 39(11):1764-7. PubMed ID: 24160385
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas keratitis.
Yilmaz S; Saklamaz A; Maden A
Ophthalmology; 2006 May; 113(5):883-4. PubMed ID: 16650685
[No Abstract] [Full Text] [Related]
12. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
[TBL] [Abstract][Full Text] [Related]
13. Multiresistant Pseudomonas keratitis.
Ku JY; Kim P; Tong J; Wechsler A; McCluskey P
Clin Exp Ophthalmol; 2010 Nov; 38(8):818-9. PubMed ID: 20572829
[No Abstract] [Full Text] [Related]
14. In Vitro Antibiotic Susceptibility of Pseudomonas aeruginosa Corneal Ulcer Isolates.
Gupta S; Mittal S; Nayak N; Satpathy G; Khokhar S; Agarwal T
Ocul Immunol Inflamm; 2015 Jun; 23(3):252-5. PubMed ID: 24564536
[No Abstract] [Full Text] [Related]
15. Pseudomonas keratitis after laser in situ keratomileusis.
Sharma N; Sinha R; Singhvi A; Tandon R
J Cataract Refract Surg; 2006 Mar; 32(3):519-21. PubMed ID: 16631068
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas keratitis associated with continuous wear silicone-hydrogel soft contact lens: a case report.
Lee KY; Lim L
Eye Contact Lens; 2003 Oct; 29(4):255-7. PubMed ID: 14555905
[TBL] [Abstract][Full Text] [Related]
18. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
[TBL] [Abstract][Full Text] [Related]
19. A case of a pseudomonas corneal ulcer in an occasional use daily disposable contact lens wearer.
Munneke R; Lash SC; Prendiville C
Eye Contact Lens; 2006 Mar; 32(2):94-5. PubMed ID: 16538131
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.
Engel LS; Hill JM; Moreau JM; Green LC; Hobden JA; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
